Advances in Clinical and Experimental Medicine

Title abbreviation: Adv Clin Exp Med
JCR Impact Factor (IF) – 2.1
5-Year Impact Factor – 2.2
Scopus CiteScore – 3.4 (CiteScore Tracker 3.4)
Index Copernicus  – 161.11; MEiN – 140 pts

ISSN 1899–5276 (print)
ISSN 2451-2680 (online)
Periodicity – monthly

Download original text (EN)

Advances in Clinical and Experimental Medicine

2011, vol. 20, nr 6, November-December, p. 711–715

Publication type: original article

Language: English

The Effects of Anti-Adhesive Low Molecular Weight Na-Hyaluronate and Octreotide on Tissue Strength

Wpływ środków przeciwzrostowych hialuronianu sodu o małej masie cząsteczkowej i oktreotydu na wytrzymałość tkanek

Baris D. Yildiz1,, Serdar Topaloglu2,, Fatih M. Avsar1,3,, Ibrahim Sakcak1,, Barlas Sulu3,, Ayse F. Avsar4,

1 Sixth Department of Surgery, Ankara Numune Training and Research Hospital, Ankara, Turkey

2 Department of General Surgery, Karadeniz Technical University Faculty of Medicine, Trabzon, Turkey

3 Department of General Surgery, Kafkas University Faculty of Medicine, Kars, Turkey

4 Department of Obstetrics and Gynecology, Atatürk Training and Research Hospital, Ankara, Turkey

Abstract

Background. The use of locally administered agents to prevent intraperitoneal adhesions is a popular research topic. The presumed effects of these agents on tissue matrix limit their use.
Objectives. To determine the effects of low-molecular-weight Na-hyaluronate and octreotide on tissue tensile strength and hydroxyproline levels. Materials and Methods. Sprague-Dawley rats were anesthetized with ketamine and 10 longitudinal incisions, 2 to 3 cm in length each, were made in the right parietal peritoneum. A 2 × 1 cm peritoneal layer was excised from the left abdominal wall during the first laparotomy. Before closing the abdomen, intraperitoneal irrigation was performed, either with Na-hyaluronate solution at a concentration of 0.25 mg/kg (n = 10) or with octreotide solution at a dosage of 5 μg/ml (n = 10). On the 14th day after the operation, the abdomen was opened and abdominal adhesions were examined. Part of the abdominal wall (4 × 4 cm in size, including midline incision) was removed to measure the tensile strength and hydroxyproline level of the tissue on the suture line.
Results. Low-molecular-weight Na-hyaluronate significantly reduced the grade of adhesion (p = 0.005). Octreotide administration inhibited adhesion formation, although not to a statistically significant degree (p > 0.05). Tissue tensile strength and hydroxyproline levels were not affected by treatment with either LMW Na-hyaluronate or octreotide (p > 0.05).
Conclusion. Na-hyaluronate and octreotide, which are well known anti-adhesive agents, do not exert any negative effects either on tissue tensile strength or hydroxyproline level.

Streszczenie

Wprowadzenie. Zapobieganie zrostom w otrzewnej za pomocą miejscowo podawanych środków jest popularnym tematem badań. Przypuszczalny wpływ tych leków na macierz tkankową może ograniczyć ich zużycie.
Cel pracy. Określenie wpływu hialuronianu sodu o małej masie cząsteczkowej i oktreotydu na wytrzymałość tkanek na rozciąganie i stężenie hydroksyproliny.
Materiał i metody. Szczury szczepu Sprague-Dawley znieczulono ketaminą i wykonano 10 nacięć wzdłużnych po 2–3 cm długości na prawej otrzewnej ściennej. Warstwę 2 × 1 cm otrzewnej wycięto z lewej ściany jamy brzusznej podczas pierwszej laparotomii. Przed zamknięciem jamy brzusznej podano dootrzewnowo roztwór hialuronianu sodu w stężeniu 0,25 mg / kg (n = 10) i roztwór oktreotydu w dawce 5 μg/ ml (n = 10). 14. dnia po operacji otwarto brzuch zwierząt i zbadano obecność zrostów w jamie brzusznej. Pobrano skrawek ściany brzucha o wielkości 4 × 4 cm, w tym nacięcie na linii środkowej, do pomiaru wytrzymałości na rozciąganie i stężenia hydroksyproliny w tkance w linii szwów.
Wyniki. Hialuronian sodu o małej masie cząsteczkowej istotnie statycznie zmniejszył intensywność powstawania zrostów (p = 0,005). Podanie oktreotydu nieistotnie statystycznie zahamowało powstawanie zrostów (p > 0,05). Podanie hialuronianu sodu o małej masie cząsteczkowej ani oktreotydu nie wpłynęło na wytrzymałość na rozciąganie tkanek i stężenie hydroksyproliny (p > 0,05).
Wnioski. Hialuronian sodu i oktreotyd, które są dobrze znanymi środkami przeciwzrostowymi nie wywierają negatywnego wpływu na wytrzymałość na rozciąganie tkanek ani stężenie hydroksyproliny.

Key words

hyaluronate, octreotide, abdominal surgery, adhesion, tissue strength

Słowa kluczowe

hialuronian, oktreotyd, chirurgia jamy brzusznej, zrost, wytrzymałość tkanki

References (25)

  1. Munireddy S, Kavalukas SL, Barbul A: Intra-abdominal healing: gastrointestinal tract and adhesions. Surg Clin North Am 2010 Dec, 90(6), 1227–1236.
  2. Menzies D: Peritoneal adhesions: incidence, cause and prevention. Surg Annu 1992, 24, 27–45.
  3. Dizerega GS: Biochemical events in peritoneal tissue repair. Eur J Surg Suppl 1997, 577, 10–16.
  4. Avsar FM, Sahin M, Aksoy F et al.: Effects of diphenhydramine HCI and methylprednisolone in the prevention of abdominal adhesions. Am J Surg 2001, 181, 512–515.
  5. Avsar FM, Sahin M, Ozel H et al.: Effects of hyaluronic acid derivatives on the post-operative peritoneal adhesions. Int J Surg Invest 2001, 3, 437–442.
  6. Lai HS, Chen Y, Chang KJ, Chen WJ: Effects of octreotide on epidermal growth factor receptor, tissue plasminogen activator, and plasminogen activator inhibitor during intraperitoneal adhesion formation. J Gastroenterol 2003, 38(6), 555–560.
  7. Kumar S, Wong PF, Leaper DJ: Intra-peritoneal prophylactic agents for preventing adhesions and adhesive intestinal obstruction after non-gynaecological abdominal surgery. Cochrane Database Syst Rev 2009 Jan 21, 1, CD005080.
  8. Mazuji MK, Kalambaheti K, Pawar B: Prevention of adhesions with polyvinylprolidone. Arch Surg 1964, 89, 1011–1014.
  9. Savunen TJA, Viljanto JA: Prediction of wound tension strength, an experimental study. Br J Surg 1992, 79, 401– 403.
  10. Miro D, Julia MV, Sitges-Serra A: Wound breaking strength and healing after suturing noninjured tissues. J Am Col Surg 1995, 180, 659–665.
  11. Bergman I, Loxley R: The determination of hydroxyproline in urine hydrolysates. Clin Chim Acta 1970, 27, 347– 349.
  12. Bergman I, Loxley R: Two improved and simplified methods for spectrophotometric determination of hydroxyproline. Anal Chem 1970, 35, 1961–1965.
  13. Dizerega GS: Biochemical events in peritoneal tissue repair. Eur J Surg Suppl 1997, 577, 10–16.
  14. Tran HS, Chrzanowski FA, Puc MM et al.: An in vivo evaluation of a chondroitin sulfate solution to prevent postoperative intraperitoneal adhesion formation. J Surg Res 2000, 88, 78–87.
  15. Holmdahl L: The role of fibrinolysis in adhesion formation. Eur J Surg Suppl 1997, 577, 24–31.
  16. Rodgers KE, DiZerega GS: Function of peritoneal exudate cells after abdominal surgery. J Invest Surg 1993, 6, 9–23.
  17. Ellis H: The clinical significance of adhesions: Focus on intestinal obstruction. Eur J Surg Suppl 1997, 577, 5–9.
  18. Adams ME, Lussier AJ, Peyran JG: A risk-benefit assessment of injections of hyaluronan and its derivatives in the treatment of osteoarthritis of the knee. Drug Safety 2000, 23, 115–130.
  19. Diamond MP: Reduction of de novo postsurgical adhesions by intraoperative precoating with Sepracoat (HAL-C) solution: a prospective randomized, blinded, placebo-controlled multicenter study. Fertil Infertil 1998, 69, 1067– 1074.
  20. Becker JM, Davton MT, Fazio VW et al.: Prevention of post-operative abdominal adhesions by a sodium hyaluronat based bioabsorbable membrane: a prospective, randomised, double-blinded multicenter study. J Am Coll Surg 1996, 183, 297–306.
  21. Burns JW, Skinner K, Colt J et al.: Prevention of tissue injury and postsurgical adhesions by precoating tissues with hyaluronic ascid solutions. J Surg Res 1995; 59, 644–652.
  22. Tsuzaki S, Moses AC: Somatostatin inhibits deoxyribonucleic acid synthesis induced by both thyrotropin and insulinlike growth factor-1 in FTRL-5 cells. Endocrinol 1990, 126, 3131–3138.
  23. Malec P, Zeman K, Markiewicz K et al.: Short-term Somatostatin infusion affects T lymphocyte responsiveness in humans. Immunopharmacology 1989, 17, 45–49.
  24. Lai HS, Chen Y: Effect of octreotide on post-operative intraperitoneal adhesions in rats. Scand J Gastroenterol 1996, 31, 678–681.
  25. Alatas E, Günal O, Alatas O et al.: Octreotide prevents postroperative adhesion formation by suppressing peritoneal myeloperoxidase activity. Hepatogastroenterology 2000, 47, 1034–1036.
© Wroclaw Medical University